• Exchange: New York
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Haemonetics Corp

+ Add to Watchlist

HAE:US

33.2100 USD 0.1900 0.58%

As of 20:04:06 ET on 04/17/2014.

Snapshot for Haemonetics Corp (HAE)

Open: 32.9600 Day's Range: 32.9300 - 33.3800 Volume: 256,465
Previous Close: 33.0200 52wk Range: 31.6200 - 45.9000 1-Yr Rtn: -16.41%

Stock Chart for HAE

No chart data available.
  • HAE:US 33.2100
  • 1D
  • 1M
  • 1Y
33.0200
Interactive HAE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HAE

Current P/E Ratio (ttm) 17.6714
Estimated P/E(03/2014) 14.3704
Relative P/E vs. SPX 1.0290
Earnings Per Share (USD) (ttm) 1.8793
Est. EPS (USD) (03/2014) 2.3110
Est. PEG Ratio 1.2144
Market Cap (M USD) 1,723.23
Shares Outstanding (M) 51.89
30 Day Average Volume 739,200
Price/Book (mrq) 2.0882
Price/Sale (ttm) 1.8033
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HAE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HAE

Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The Company's products are for use in surgical blood salvage, blood component collections, and plasma collections. Haemonetics markets its products worldwide, primarily outside the United States.

Brian P ConcannonPresident/CEOPeter M AllenPresident:Global Plasma
Christopher J LindopVP:Business Development/CFODavid D Helsel "Dave"VP:Global Manufacturing
More Company Profile & Key Executives for HAE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil